Source:http://linkedlifedata.com/resource/pubmed/id/21784902
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2011-8-1
|
pubmed:abstractText |
TGF-?/Smad3 signaling promotes fibrosis, but the development of therapeutic interventions involving this pathway will require the identification and ultimate targeting of downstream fibrosis-specific genes. In this study, using a microRNA microarray and real-time PCR, wild-type mice had reduced expression of miR-29 along with the development of progressive renal fibrosis in obstructive nephropathy. In contrast, Smad3 knockout mice had increased expression of miR-29 along with the absence of renal fibrosis in the same model of obstruction. In cultured fibroblasts and tubular epithelial cells, Smad3 mediated TGF-?(1)-induced downregulation of miR-29 by binding to the promoter of miR-29. Furthermore, miR-29 acted as a downstream inhibitor and therapeutic microRNA for TGF-?/Smad3-mediated fibrosis. In vitro, overexpression of miR-29b inhibited, but knockdown of miR-29 enhanced, TGF-?(1)-induced expression of collagens I and III by renal tubular cells. Ultrasound-mediated gene delivery of miR-29b either before or after established obstructive nephropathy blocked progressive renal fibrosis. In conclusion, miR-29 is a downstream inhibitor of TGF-?/Smad3-mediated fibrosis and may have therapeutic potential for diseases involving fibrosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/MIRN29 microRNA, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/MicroRNAs,
http://linkedlifedata.com/resource/pubmed/chemical/Smad3 Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Smad3 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1533-3450
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1462-74
|
pubmed:meshHeading |
pubmed-meshheading:21784902-Animals,
pubmed-meshheading:21784902-Fibroblasts,
pubmed-meshheading:21784902-Fibrosis,
pubmed-meshheading:21784902-Kidney Diseases,
pubmed-meshheading:21784902-Male,
pubmed-meshheading:21784902-Mice,
pubmed-meshheading:21784902-Mice, Inbred C57BL,
pubmed-meshheading:21784902-Mice, Knockout,
pubmed-meshheading:21784902-MicroRNAs,
pubmed-meshheading:21784902-Promoter Regions, Genetic,
pubmed-meshheading:21784902-Signal Transduction,
pubmed-meshheading:21784902-Smad3 Protein,
pubmed-meshheading:21784902-Transforming Growth Factor beta,
pubmed-meshheading:21784902-Treatment Outcome
|
pubmed:year |
2011
|
pubmed:articleTitle |
TGF-?/Smad3 signaling promotes renal fibrosis by inhibiting miR-29.
|
pubmed:affiliation |
Department of Medicine and Therapeutics, and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, NT, Hong Kong, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|